HER2 overexpression promotes tumor cell proliferation and survival by activating key signaling pathways such as PI3K/Akt and MAPK, making it a critical factor for bladder cancer aggressiveness and prognosis. This evidence concerns the gene ERBB2 and urinary bladder carcinoma.